Company-level financial information
Astrana Health, Inc.
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 114.6 | SEC filingMar 12, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 22.5 | SEC filingMar 12, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 7.9 | SEC filingMar 12, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 10.1 | SEC filingMar 12, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 52.2 | SEC filingMar 12, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 43.1 | SEC filingMar 12, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 4.0 | SEC filingMar 12, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 8.0 | SEC filingMar 12, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 68.2 | SEC filingMar 12, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 60.7 | SEC filingMar 12, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 62.1 | SEC filingMar 12, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 28.5 | SEC filingMar 12, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 82.1 | SEC filingMar 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 45.2 | SEC filingMar 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 14.0 | SEC filingMar 14, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 22.9 | SEC filingMar 14, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 70.3 | SEC filingFeb 29, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 68.9 | SEC filingFeb 29, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 31.1 | SEC filingFeb 29, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 19.2 | SEC filingFeb 29, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 46.2 | SEC filingAug 9, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 37.7 | SEC filingAug 9, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 51.3 | SEC filingAug 9, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 1.2 | SEC filingAug 9, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 13.7 | SEC filingFeb 28, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 14.1 | SEC filingFeb 28, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Total cash dividends | 61.7 | SEC filingMar 16, 2020 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 61.7 | SEC filingFeb 28, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 1.0 | SEC filingFeb 28, 2022 |